Goldman Sachs named Vertex Pharmaceuticals a top healthcare stock pick on July 15, 2025.
3 reports, 2 independent
Updated Aug 19
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 3
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Goldman Sachs named Vertex Pharmaceuticals a top healthcare stock pick on July 15, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Goldman Sachs reiterated a Buy rating on Vertex Pharmaceuticals.1 source
GS and BofM provided financing for RMR deal; Vertex HQ in Boston Seaport District.1 source
Goldman Sachs named Vertex Pharmaceuticals a top healthcare stock pick.1 source
Keep exploring
The entities involved
-
Goldman Sachs
American investment bank
-
Vertex Pharmaceuticals
American pharmaceutical company
Related events
- Goldman Sachs updated its top stock picks, removing Interactive Brokers and adding Vertex Pharmaceuticals.
- Vertex Pharmaceuticals presented updates at a Wells Fargo conference on September 12, 2026.
- Vertex Pharmaceuticals trades on Nasdaq, files reports with the SEC, and has an executive named Duncan McKechnie.
- Vertex Pharmaceuticals CEO leads the company's strategic business direction.
- Goldman Sachs manages the investments for the Goldman Sachs Future Health Care Equity ETF.
Coverage
Newest first; wire copies grouped- Insider MonkeyGoldman Sachs Reiterated a Buy Rating on Vertex Pharmaceuticals (VRTX), Kept the PT Unchanged Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the Most Profitable Large Cap Stocks to Buy A
- Business WireThe RMR Group Announces $1.0 Billion Refinancing of Vertex Pharmaceuticals’ Headquarters in Boston Seaport District NEWTON, Mass., August 07, 2025--(BUSINESS WIRE)--The RMR Group (Nasdaq: RMR) today
- Insider MonkeyEU Commission Approves Vertex Pharmaceutical’s (VRTX) Cystic Fibrosis Treatment Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of Goldman Sachs’ top healthcare stock picks. On July 1, the E